Which medication is typically not used in the treatment of Polymyalgia rheumatica?

Polymyalgia rheumatica is primarily treated with corticosteroids, particularly low-dose long-term steroids, which are effective in alleviating symptoms such as pain and stiffness. High-dose corticosteroids may also be used, particularly in more severe cases or when a rapid response is necessary. Additionally, non-steroidal anti-inflammatory drugs (NSAIDs) can be utilized to manage symptoms, although they are generally less effective compared to corticosteroids.

Biologic agents, while they have been used in the treatment of other inflammatory conditions like rheumatoid arthritis, are not typically part of the standard treatment for polymyalgia rheumatica. This is because the condition primarily responds well to corticosteroids, and the use of biologic therapies is reserved for other specific indications and is not established for polymyalgia rheumatica due to a lack of sufficient evidence supporting their effectiveness for this particular disorder. Therefore, choosing biologic agents in this context demonstrates a misunderstanding of the standard treatment protocols for polymyalgia rheumatica.